These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 25859669)
1. Risk communication of vaccines: challenges in the post-trust environment. Bouder F Curr Drug Saf; 2015; 10(1):9-15. PubMed ID: 25859669 [TBL] [Abstract][Full Text] [Related]
2. Editorial: Communicating vaccine safety - the Vienna Vaccine Safety Initiative. Rath B Curr Drug Saf; 2015; 10(1):3-4. PubMed ID: 25859667 [No Abstract] [Full Text] [Related]
3. Historical aspects of immunization and vaccine safety communication. Helfert SM Curr Drug Saf; 2015; 10(1):5-8. PubMed ID: 25859668 [TBL] [Abstract][Full Text] [Related]
4. Communicating vaccine safety to the media and general public. Oubari H; Tuttle R; Rath B; Bravo L Curr Drug Saf; 2015; 10(1):80-6. PubMed ID: 25859680 [TBL] [Abstract][Full Text] [Related]
5. Communicating vaccine safety in the context of immunization programs in low resource settings. Arwanire EM; Mbabazi W; Mugyenyi P Curr Drug Saf; 2015; 10(1):68-75. PubMed ID: 25859678 [TBL] [Abstract][Full Text] [Related]
6. Communicating vaccine safety during the development and introduction of vaccines. Kochhar S Curr Drug Saf; 2015; 10(1):55-9. PubMed ID: 25859676 [TBL] [Abstract][Full Text] [Related]
7. The need to teach vaccine safety to basic scientists and public health officials. Khamesipour A Curr Drug Saf; 2015; 10(1):76-9. PubMed ID: 25859679 [TBL] [Abstract][Full Text] [Related]
8. Why some messages speak better: child immunization in the news and on the internet. Rundblad G Curr Drug Saf; 2015; 10(1):87-93. PubMed ID: 25859681 [TBL] [Abstract][Full Text] [Related]
9. Vaccine safety monitoring systems in developing countries: an example of the Vietnam model. Ali M; Rath B; Thiem VD Curr Drug Saf; 2015; 10(1):60-7. PubMed ID: 25859677 [TBL] [Abstract][Full Text] [Related]
10. The impact of the parent-physician relationship on parental vaccine safety perceptions. Kundi M; Obermeier P; Helfert S; Oubari H; Fitzinger S; Yun JA; Brix M; Rath B Curr Drug Saf; 2015; 10(1):16-22. PubMed ID: 25859670 [TBL] [Abstract][Full Text] [Related]
11. A design thinking approach to effective vaccine safety communication. Seeber L; Michl B; Rundblad G; Trusko B; Schnjakin M; Meinel C; Weinberg U; Gaedicke G; Rath B Curr Drug Saf; 2015; 10(1):31-40. PubMed ID: 25859673 [TBL] [Abstract][Full Text] [Related]
12. Vaccine hesitancy and trust. Ethical aspects of risk communication. Nihlén Fahlquist J Scand J Public Health; 2018 Mar; 46(2):182-188. PubMed ID: 28847220 [TBL] [Abstract][Full Text] [Related]
13. Vaccine trust and the limits of information. Larson HJ Science; 2016 Sep; 353(6305):1207-8. PubMed ID: 27634512 [No Abstract] [Full Text] [Related]
14. Dilemmas of a vitalizing vaccine market: lessons from the MMR vaccine/autism debate. Bragesjö F; Hallberg M Sci Context; 2011 Mar; 24(1):107-25. PubMed ID: 21560548 [TBL] [Abstract][Full Text] [Related]
15. Teaching vaccine safety communication to medical students and health professionals. Rath B; Muhlhans S; Gaedicke G Curr Drug Saf; 2015; 10(1):23-6. PubMed ID: 25859671 [TBL] [Abstract][Full Text] [Related]
16. Controlled language and information on vaccines: application to package inserts. Renahy J; Vuitton DA; Rath B; Thomas I; de Grivel V; Cardey S Curr Drug Saf; 2015; 10(1):41-8. PubMed ID: 25859674 [TBL] [Abstract][Full Text] [Related]
17. Managing controversy through consultation: a qualitative study of communication and trust around MMR vaccination decisions. McMurray R; Cheater FM; Weighall A; Nelson C; Schweiger M; Mukherjee S Br J Gen Pract; 2004 Jul; 54(504):520-5. PubMed ID: 15239914 [TBL] [Abstract][Full Text] [Related]
18. The importance of precise documentation of vaccination by physicians and vaccine providers. Maurer W Curr Drug Saf; 2015; 10(1):27-30. PubMed ID: 25859672 [TBL] [Abstract][Full Text] [Related]
19. Listen to the public and fulfil their information interests - translating vaccine communication research findings into guidance for regulators. Bahri P; Castillon Melero M Br J Clin Pharmacol; 2018 Aug; 84(8):1696-1705. PubMed ID: 29573274 [TBL] [Abstract][Full Text] [Related]
20. The "Fluad Case" in Italy: Could it have been dealt differently? Levi M; Sinisgalli E; Lorini C; Santomauro F; Chellini M; Bonanni P Hum Vaccin Immunother; 2017 Feb; 13(2):379-384. PubMed ID: 27924687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]